Best Income Stocks to Buy for September 14th

Zacks highlighted Ternium, HP and Takeda as income-oriented buy candidates after current-year consensus EPS estimates rose 26.7%, 8.4% and 10.7%, respectively, over the past 60 days. The article provides favorable analyst-revision signals but no new company operating results, guidance changes, or valuation data, limiting likely market impact.

Analysis

This is a low-information screening item rather than a fundamental catalyst; estimate revisions alone are insufficient without identifying whether they reflect revenue acceleration, lower costs, FX, or one-off items. The modest likely flow effect is concentrated in retail and income-oriented mandates and should fade within days, making any opening strength a liquidity event rather than confirmation of a durable rerating.

TX has the clearest cyclical torque, but its earnings sensitivity is principally to Latin American steel spreads, regional demand, and iron-ore/coking-coal costs. A sustained rerating over 1-3 months requires improving Brazilian/Mexican industrial indicators and stable steel pricing; otherwise the revised estimates can reverse quickly. The relevant competitive read-through is Nucor (NUE), Steel Dynamics (STLD), Commercial Metals (CMC), and CLF, though TX's regional mix makes a direct U.S.-steel extrapolation unreliable.

HPQ's key issue is whether PC-unit recovery converts into pricing and gross-margin durability amid aggressive AI-PC competition from Lenovo and Dell (DELL). Buybacks and dividend support can cushion downside, but the stock needs evidence of stable print supplies economics and improving commercial-PC mix to outperform over 6-18 months. For TAK, the more investable question is whether pipeline execution and post-launch growth can offset patent-expiry exposure; an earnings revision does not resolve that structural multiple constraint.

Contrarian view: the income screen may attract capital precisely toward mature, lower-growth businesses where dividend yield can be a symptom of limited reinvestment opportunities. Do not infer a broad risk-on signal from the inclusion of QBTS in the ticker data: it is unrelated to the underlying screen and should not receive a sympathy bid absent company-specific quantum-computing orders, funding, or cash-runway news.

Key Decisions for Investors

• No immediate directional trade on the screen publication; monitor 1-3 day volume and price response, then treat a >5% move in HPQ, TAK, or TX without corroborating guidance or sector data as a fade candidate rather than momentum confirmation.
• Watch-list long TX versus short NUE or STLD over 1-3 months only if Latin American steel benchmarks and Mexican industrial production improve while iron-ore costs remain contained; target 8-12% relative upside, with exit if steel spreads contract for two consecutive monthly observations or TX cuts EBITDA guidance.
• Maintain neutral HPQ until the next earnings release validates commercial-PC mix, print-supplies margin, and free-cash-flow conversion. A long HPQ / short DELL pair is actionable only if HPQ guides to margin stability while DELL's AI-server mix faces gross-margin pressure; otherwise the superior growth profile remains with DELL.
• For TAK, use ADR weakness around broader pharma risk-off to evaluate a defensive income position, not a revision-chasing entry. Require confirmation of launch uptake and unchanged full-year guidance; pipeline setbacks or accelerated biosimilar erosion would falsify the thesis and warrant avoiding the name.
• Exclude QBTS from any basket derived from this item. Set an alert for material bookings, capital raise, or liquidity disclosure, as cash financing risk—not sentiment spillover—is the dominant 6-18 month driver.